Home | All trials

[RDF data]
Trial NCT00000318

Resource URI: http://static.linkedct.org/resource/trials/NCT00000318
PropertyValue
linkedct:arm_group <http://static.linkedct.org/resource/arm_group/18448>
linkedct:arm_group <http://static.linkedct.org/resource/arm_group/6451>
linkedct:brief_title Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/9346>
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 55 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:end_date August 2007
linkedct:enrollment 202 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:has_dmc No
linkedct:id NCT00000318
linkedct:intervention <http://static.linkedct.org/resource/intervention/71627>
rdfs:label Trial NCT00000318
linkedct:lastchanged_date December 17, 2008
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/150283>
linkedct:nct_id NCT00000318
linkedct:number_of_arms 2 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot
linkedct:org_study_id NIDA-09803-1
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/50041>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000318>
linkedct:phase Phase 2
linkedct:primary_completion_date March 2004
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/38875>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/38906>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/38927>
linkedct:secondary_id R01-09803-1
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date December 1994
linkedct:study_design Treatment, Randomized, Open Label, Factorial Assignment, Efficacy Study
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.
rdf:type linkedct:trials
linkedct:verification_date December 2008